XML 26 R9.htm IDEA: XBRL DOCUMENT
v2.4.0.8

Accrued expenses and other current liabilities | 9 Months Ended
--- | ---
Sep. 30, 2014
Accrued expenses and other current liabilities | 2. Accrued expenses and other current liabilities Accrued expenses and other current liabilities were comprised of the following (in thousands):
|  | September 30, 2014 |  |  | December 31, 2013 |
Salary and related expenses |  | $ | 10,287 |  |  | $ | 12,193 |
Research and clinical trial costs |  |  | 1,011 |  |  |  | 1,311 |
Accrued interest |  |  | 958 |  |  |  | 2,082 |
Construction in progress |  |  | 2,739 |  |  |  | 342 |
Other |  |  | 12,274 |  |  |  | 5,706 |
Accrued expenses and other current liabilities |  | $ | 27,269 |  |  | $ | 21,634 |

X
- Definition The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.19(a),20,24) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 19 -Subparagraph a -Article 5 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 20, 24 -Article 5 + Details
Name: | us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration